79 related articles for article (PubMed ID: 15548359)
1. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anti-angiogenic activities of Panduratin A.
Lai SL; Cheah SC; Wong PF; Noor SM; Mustafa MR
PLoS One; 2012; 7(5):e38103. PubMed ID: 22666456
[TBL] [Abstract][Full Text] [Related]
3. A novel poly-naphthol compound ST104P suppresses angiogenesis by attenuating matrix metalloproteinase-2 expression in endothelial cells.
Ma YL; Lin SW; Fang HC; Chou KJ; Bee YS; Chu TH; Chang MC; Weng WT; Wu CY; Cho CL; Tai MH
Int J Mol Sci; 2014 Sep; 15(9):16611-27. PubMed ID: 25244013
[TBL] [Abstract][Full Text] [Related]
4. Effects of metabolic cancer therapy on tumor microenvironment.
Hyroššová P; Milošević M; Škoda J; Vachtenheim J; Rohlena J; Rohlenová K
Front Oncol; 2022; 12():1046630. PubMed ID: 36582801
[TBL] [Abstract][Full Text] [Related]
5. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Cell Glucose Metabolism and Angiogenesis.
Du W; Ren L; Hamblin MH; Fan Y
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33546224
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
[TBL] [Abstract][Full Text] [Related]
8. Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner.
Ocaña MC; Martínez-Poveda B; Marí-Beffa M; Quesada AR; Medina MÁ
Sci Rep; 2020 Apr; 10(1):6132. PubMed ID: 32273578
[TBL] [Abstract][Full Text] [Related]
9. ROS homeostasis and metabolism: a critical liaison for cancer therapy.
Kim J; Kim J; Bae JS
Exp Mol Med; 2016 Nov; 48(11):e269. PubMed ID: 27811934
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
[TBL] [Abstract][Full Text] [Related]
11. Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma.
Hirashima K; Baba Y; Watanabe M; Karashima RI; Sato N; Imamura Y; Nagai Y; Hayashi N; Iyama KI; Baba H
Br J Cancer; 2012 Feb; 106(5):876-82. PubMed ID: 22333597
[TBL] [Abstract][Full Text] [Related]
12. Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.
Milane L; Duan Z; Amiji M
Mol Pharm; 2011 Feb; 8(1):185-203. PubMed ID: 20942457
[TBL] [Abstract][Full Text] [Related]
13. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
[TBL] [Abstract][Full Text] [Related]
14. A review of the past, present, and future directions of neoplasia.
Rehemtulla A; Ross BD
Neoplasia; 2005 Dec; 7(12):1039-46. PubMed ID: 16354585
[No Abstract] [Full Text] [Related]
15. Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.
Del Bufalo D; Trisciuoglio D; Scarsella M; D'Amati G; Candiloro A; Iervolino A; Leonetti C; Zupi G
Neoplasia; 2004; 6(5):513-22. PubMed ID: 15548359
[TBL] [Abstract][Full Text] [Related]
16. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
17. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
18. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
19. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]